These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16400620)

  • 1. Pharmacokinetics of oral amlodipine orotate in vagotomized dogs.
    Kwak HH; Kim JO; Chung HK; Choi SM; Kim JH; Kwon JW; Yoo M; Lee JH; Lee MG
    Biopharm Drug Dispos; 2006 Apr; 27(3):141-5. PubMed ID: 16400620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability cf two amlodipine formulation in healthy volunteers.
    Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH
    Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry.
    Ma Y; Qin F; Sun X; Lu X; Li F
    J Pharm Biomed Anal; 2007 Mar; 43(4):1540-5. PubMed ID: 17174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
    Fourtillan JB; Ingrand I; Decourt JP; Istin B; Girault J
    Therapie; 1998; 53(2):121-6. PubMed ID: 9773111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers.
    Mignini F; Tomassoni D; Traini E; Amenta F
    Clin Exp Hypertens; 2007 Nov; 29(8):539-52. PubMed ID: 18058479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal permeability and excretion into bile control the arrival of amlodipine into the systemic circulation after oral administration.
    Rausl D; Fotaki N; Zanoski R; Vertzoni M; Cetina-Cizmek B; Khan MZ; Reppas C
    J Pharm Pharmacol; 2006 Jun; 58(6):827-36. PubMed ID: 16734984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
    Abernethy DR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.
    Wang R; Zhang H; Sun S; Wang Y; Chai Y; Yuan Y
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):825-833. PubMed ID: 26650374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.
    Kim KA; Park PW; Lee OJ; Choi SH; Min BH; Shin KH; Chun BG; Shin JG; Park JY
    Clin Pharmacol Ther; 2006 Dec; 80(6):646-56. PubMed ID: 17178265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
    Park JY; Kim KA; Park PW; Lee OJ; Kim JS; Lee GH; Ha MC; Park JH; O MJ; Ryu JH
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):641-7. PubMed ID: 17190374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited-sampling strategy models for estimating the area under the plasma concentration-time curve for amlodipine.
    Suarez-Kurtz G; Vicente FL; Ponte CG; Buy VL; Struchiner CJ
    Eur J Clin Pharmacol; 1999 Nov; 55(9):651-7. PubMed ID: 10638394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects.
    Kim KA; Park PW; Park JY
    Br J Clin Pharmacol; 2007 Jan; 63(1):53-8. PubMed ID: 16869811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
    Chung M; Calcagni A; Glue P; Bramson C
    J Clin Pharmacol; 2006 Sep; 46(9):1030-7. PubMed ID: 16920898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis.
    Kungys G; Naujoks H; Wanner C
    Eur J Clin Pharmacol; 2003 Aug; 59(4):291-5. PubMed ID: 12845505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective disposition of oral amlodipine in healthy volunteers.
    Laufen H; Leitold M
    Chirality; 1994; 6(7):531-6. PubMed ID: 7986667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC; Sams RA; Bonagura JD
    J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.